Tomokazu Watanabe
Overview
Explore the profile of Tomokazu Watanabe including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
32
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tezuka T, Sato R, Itoh J, Kobayashi T, Watanabe T, Chiba K, et al.
Development
. 2024 Aug;
151(16).
PMID: 39206939
Shoot apical meristems (SAMs) continuously initiate organ formation and maintain pluripotency through dynamic genetic regulations and cell-to-cell communications. The activity of meristems directly affects the plant's structure by determining the...
2.
Deguchi Y, Komuta W, Watanabe T, Saiga K, Kurahashi K, Otsuka K, et al.
Am J Case Rep
. 2022 Oct;
23:e936806.
PMID: 36227783
BACKGROUND Solitary fibrous tumors (SFT), rare soft-tissue neoplasms, are usually found in the thoracic cavity, and a uterine origin is extremely rare. SFTs with insulin-like growth factor-II (IGF-II) production induce...
3.
Yoshioka F, Nirengi S, Murata T, Kawaguchi Y, Watanabe T, Saeki K, et al.
J Diabetes Investig
. 2021 Feb;
12(9):1689-1696.
PMID: 33615741
Aims/introduction: Type 1 diabetes is associated with poorer bone quality. Quantitative ultrasound provides an estimate of bone mineral density (BMD) and can also be used to evaluate bone quality, which...
4.
Murata T, Kuroda A, Matsuhisa M, Toyoda M, Kimura M, Hirota Y, et al.
J Diabetes Sci Technol
. 2020 Aug;
15(5):1084-1092.
PMID: 32762345
Background: Information about factors related to better adherence to continuous glucose monitoring (CGM) sensor adherence is quite limited. Materials And Methods: Forty-six participants with type 1 diabetes using continuous subcutaneous...
5.
Sakane N, Murata T, Tone A, Kato K, Kimura M, Kawashima S, et al.
Diabetes Technol Ther
. 2019 Oct;
22(3):216-221.
PMID: 31638420
Continuous subcutaneous insulin infusion (CSII) is associated with improved glycemic control, a reduced incidence of hypoglycemia, and improved quality of life (QOL). To date, however, there has been no QOL...
6.
Murata T, Tone A, Kouyama R, Kamiuchi K, Narasaki K, Tsuruo M, et al.
Intern Med
. 2019 Jun;
58(20):2943-2948.
PMID: 31243228
Objective We compared the pain accompanying the injection of high-concentration (300 units/mL) insulin glargine (U300G) with that accompanying the injection of conventional (100 units/mL) insulin glargine (U100G). Methods U100G was...
7.
Murata T, Tsuzaki K, Nirengi S, Watanabe T, Mizutani Y, Okada H, et al.
J Diabetes Investig
. 2016 Nov;
8(4):475-479.
PMID: 27863109
Aims/introduction: The distributer of the anti-glutamic acid decarboxylase antibody assay kit using radioimmunoassay (RIA) recently announced its discontinuation, and proposed an alternative kit using enzyme-linked immunosorbent assay (ELISA). The aim...